Peripheral blood stem cells for allogeneic transplantation: a review
C Cutler, JH Antin - Stem cells, 2001 - academic.oup.com
Peripheral blood stem cells (PBSCs) have become increasingly popular for use in
hematopoietic stem cell transplantation. PBSCs are readily collected by continuous-flow …
hematopoietic stem cell transplantation. PBSCs are readily collected by continuous-flow …
[HTML][HTML] Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
J Greiner, M Ringhoffer, M Taniguchi, A Schmitt… - Experimental …, 2002 - Elsevier
OBJECTIVE: Identification of leukemia-associated antigens (LAA) eliciting an immune
response in patients is a prerequisite for specific immunotherapy of leukemias. To identify …
response in patients is a prerequisite for specific immunotherapy of leukemias. To identify …
[HTML][HTML] Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first …
SS Farag, K Maharry, MJ Zhang, WS Pérez… - Biology of Blood and …, 2011 - Elsevier
We compared the outcomes of patients age 60-70 years with acute myelogenous leukemia
receiving reduced-intensity allogeneic hematopoietic cell transplantation (HCT) in first …
receiving reduced-intensity allogeneic hematopoietic cell transplantation (HCT) in first …
131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first …
JM Pagel, FR Appelbaum, JF Eary, J Rajendran… - Blood, 2006 - ashpublications.org
In an attempt to improve outcomes for patients with acute myeloid leukemia (AML) after
allogeneic hematopoietic cell transplantation (HCT), we conducted a phase 1/2 study in …
allogeneic hematopoietic cell transplantation (HCT), we conducted a phase 1/2 study in …
Definition of a standard‐risk group in children with AML
U Creutzig, M Zimmermann, J Ritter… - British journal of …, 1999 - Wiley Online Library
To define paediatric AML patients with a favourable outcome in order to design a risk‐
adapted therapy, we analysed 489 children under 17 years of age treated similarly in …
adapted therapy, we analysed 489 children under 17 years of age treated similarly in …
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study
SS Farag, AS Ruppert, K Mrózek, RJ Mayer… - Journal of clinical …, 2005 - ascopubs.org
Purpose Evaluate the outcome of induction and postremission therapy in adults younger
than 60 years with normal cytogenetics acute myeloid leukemia (AML). Patients and …
than 60 years with normal cytogenetics acute myeloid leukemia (AML). Patients and …
Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic …
I Jedema, RMY Barge, VHJ Van Der Velden… - Leukemia, 2004 - nature.com
Multicenter phase II trials with Gemtuzumab Ozogamicin (GO/Mylotarg®), consisting of a
CD33 antibody linked to the cytotoxic drug calicheamicin, have shown a 30% overall …
CD33 antibody linked to the cytotoxic drug calicheamicin, have shown a 30% overall …
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia …
AM Martelli, PL Tazzari, G Tabellini… - Leukemia …, 2003 - search.ebscohost.com
It is now well established that the reduced capacity of tumor cells of undergoing cell death
through apoptosis plays a key role both in the pathogenesis of cancer and in therapeutic …
through apoptosis plays a key role both in the pathogenesis of cancer and in therapeutic …
Adult acute myeloid leukemia
EJ Jabbour, E Estey, HM Kantarjian - Mayo Clinic Proceedings, 2006 - Elsevier
Acute myeloid leukemia (AML) is a group of several different diseases, the treatment and
outcome of which depend on several factors, including leukemia karyotype, patient age, and …
outcome of which depend on several factors, including leukemia karyotype, patient age, and …
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course
KH Lee, JH Lee, SJ Choi, S Kim, M Seol… - Bone marrow …, 2003 - nature.com
A total of 118 consecutive adult patients with acute leukemia (78 AML, 36 ALL, and four
acute mixed lineage leukemia) underwent allogeneic hematopoietic cell transplantation …
acute mixed lineage leukemia) underwent allogeneic hematopoietic cell transplantation …